Has Asaad Elbashir received payments from drug or device companies?

Yes. Drug and device makers reported $2,370 in general payments to Asaad Elbashir across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Asaad Elbashir did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Asaad Elbashir come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Asaad Elbashir

Pediatric Endocrinology · Modesto, CANPI 1841558657

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $809, 2.7 times the $305 reported in 2019.

$2,370in general payments, 2019–2025

Across 82 payments — averaging $28.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$390
AbbVie$348
Sanofi-aventis U.S. LLC$293
Dexcom, Inc.$218
Abbott$193
Tolmar, Inc.$144
plus $783 from 19 others

What the payments were for

Food & beverage$2,28296%
Education$884%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	16	$390
AbbVie	11	$348
Sanofi-aventis U.S. LLC	5	$293
Dexcom, Inc.	6	$218
Abbott	3	$193
Tolmar, Inc.	6	$144
AstraZeneca	6	$127
Kyowa Kirin, Inc.	4	$91
BETA Bionics, Inc.	2	$60
Sobi, Inc	1	$52
Tandem Diabetes Care, Inc.	2	$50
UCB, Inc.	2	$47
Xeris Pharmaceuticals, Inc.	2	$43
Azurity Pharmaceuticals, Inc.	2	$42
Neurocrine Biosciences, Inc.	2	$41
Soleno Therapeutics, Inc.	1	$34
Lilly USA, LLC	2	$33
Arbor Pharmaceuticals, Inc.	2	$31
Rhythm Pharmaceuticals, Inc.	1	$23
Endo Pharmaceuticals Inc.	1	$21
Ferring Pharmaceuticals Inc.	1	$21
Amphastar Pharmaceuticals, Inc.	1	$20
Zogenix Inc.	1	$18
Medtronic	1	$15
Catalyst Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,370 in reported general payments places this provider in the 60th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California →

Other pediatric endocrinology in Modesto

Ethel ClementeModesto$3K
Gnanagurdasan PrakasamSacramento$805K
Swati ElchuriVentura$210K
Karen KleinSan Diego$195K
Francine KaufmanLos Angeles$184K
Lynda PolgreenOrange$167K
Kevin KaisermanWest Covina$150K
Amrit BhangooLong Beach$140K
Mitchell GeffnerLos Angeles$129K
Stephen GitelmanSan Francisco$105K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →